Ameritas Investment Partners’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.7K | Hold |
7,797
| – | – | ﹤0.01% | 2612 |
|
|
2026
Q1 | $27.9K | Hold |
7,797
| – | – | ﹤0.01% | 2434 |
|
|
2025
Q4 | $27.4K | Hold |
7,797
| – | – | ﹤0.01% | 2490 |
|
|
2025
Q3 | $25.4K | Hold |
7,797
| – | – | ﹤0.01% | 2558 |
|
|
2025
Q2 | $19.1K | Hold |
7,797
| – | – | ﹤0.01% | 2682 |
|
|
2025
Q1 | $52K | Buy |
7,797
+1,303
| +20% | +$12.9K | ﹤0.01% | 2079 |
|
|
2024
Q4 | $81.6K | Hold |
6,494
| – | – | ﹤0.01% | 1901 |
|
|
2024
Q3 | $120K | Hold |
6,494
| – | – | ﹤0.01% | 1670 |
|
|
2024
Q2 | $140K | Hold |
6,494
| – | – | ﹤0.01% | 1509 |
|
|
2024
Q1 | $175K | Hold |
6,494
| – | – | 0.01% | 1377 |
|
|
2023
Q4 | $195K | Buy |
6,494
+920
| +17% | +$20.3K | 0.01% | 1280 |
|
|
2023
Q3 | $114K | Buy |
5,574
+1,274
| +30% | +$23.2K | ﹤0.01% | 1555 |
|
|
2023
Q2 | $85.4K | Hold |
4,300
| – | – | ﹤0.01% | 1704 |
|
|
2023
Q1 | $73.7K | Hold |
4,300
| – | – | ﹤0.01% | 1733 |
|
|
2022
Q4 | $87.9K | Buy |
4,300
+1,291
| +43% | +$23.8K | ﹤0.01% | 1688 |
|
|
2022
Q3 | $48K | Hold |
3,009
| – | – | ﹤0.01% | 2008 |
|
|
2022
Q2 | $41K | Hold |
3,009
| – | – | ﹤0.01% | 2128 |
|
|
2022
Q1 | $48K | Hold |
3,009
| – | – | ﹤0.01% | 2084 |
|
|
2021
Q4 | $66K | Hold |
3,009
| – | – | ﹤0.01% | 1960 |
|
|
2021
Q3 | $90K | Hold |
3,009
| – | – | ﹤0.01% | 1759 |
|
|
2021
Q2 | $133K | Hold |
3,009
| – | – | ﹤0.01% | 1550 |
|
|
2021
Q1 | $134K | Hold |
3,009
| – | – | 0.01% | 1481 |
|
|
2020
Q4 | $165K | Hold |
3,009
| – | – | 0.01% | 1261 |
|
|
2020
Q3 | $69K | Hold |
3,009
| – | – | ﹤0.01% | 1650 |
|
|
2020
Q2 | $63K | Buy |
3,009
+460
| +18% | +$8.29K | ﹤0.01% | 1695 |
|
|
2020
Q1 | $36K | Hold |
2,549
| – | – | ﹤0.01% | 1850 |
|
|
2019
Q4 | $58K | Hold |
2,549
| – | – | ﹤0.01% | 1835 |
|
|
2019
Q3 | $30K | Hold |
2,549
| – | – | ﹤0.01% | 2174 |
|
|
2019
Q2 | $38K | Buy |
2,549
+679
| +36% | +$11.8K | ﹤0.01% | 2071 |
|
|
2019
Q1 | $33K | Hold |
1,870
| – | – | ﹤0.01% | 2101 |
|
|
2018
Q4 | $28K | Hold |
1,870
| – | – | ﹤0.01% | 2147 |
|
|
2018
Q3 | $46K | Hold |
1,870
| – | – | ﹤0.01% | 2035 |
|
|
2018
Q2 | $37K | Buy |
+1,870
| New | +$35.4K | ﹤0.01% | 2176 |
|
|
2017
Q2 | – | Sell |
-340
| Closed | -$3K | – | 3031 |
|
|
2017
Q1 | $3K | Buy |
+340
| New | +$2.29K | ﹤0.01% | 2901 |
|
Other funds holding RCKT
RI
NM
MC
Ameritas Investment Partners's RCKT Position: Q2 2026 in Review
Ameritas Investment Partners held its Rocket Pharmaceuticals (RCKT) position steady in Q2 2026 at 7,797 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2612.
Ameritas Investment Partners first reported a position in RCKT in Q1 2017 and has held it in 34 quarters since. The position peaked at $195K in Q4 2023. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.
- Ameritas Investment Partners held 7,797 shares of Rocket Pharmaceuticals worth $26.7K as of Q2 2026.
- Ameritas Investment Partners left its Rocket Pharmaceuticals share count unchanged in Q2 2026.
- Rocket Pharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2612 holding.
- Ameritas Investment Partners first reported a position in Rocket Pharmaceuticals in Q1 2017 and has held it in 34 quarters since.
- Ameritas Investment Partners's Rocket Pharmaceuticals position peaked at $195K in Q4 2023.
- 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.